Evaluating,O
Potential,O
Deceased,O
Donor,O
Renal,O
Transplant,O
Recipients,O
for,O
Asymptomatic,O
COVID,O
‐,O
19,NUMBER
Quan,PERSON
Yao,PERSON
Ho,PERSON
.,O
MRCP,O
.,O
MMed,O
.1.2,O
Shimin,PERSON
Jas,PERSON
‐,PERSON
mine,O
Chung,PERSON
.,O
MRCP,O
.2.3,O
Shoen,PERSON
Choon,PERSON
Seng,PERSON
Low,PERSON
.,O
FRCR,O
.,O
MMed,O
.4,NUMBER
Robert,PERSON
Chun,PERSON
Chen,PERSON
.,O
MD,STATE_OR_PROVINCE
.4,NUMBER
Swee,PERSON
Ping,PERSON
Teh,PERSON
.,O
MRCP,O
.1,NUMBER
Fu,PERSON
Zi,PERSON
Yvonne,PERSON
Chan,PERSON
.,O
MRCP,O
.,O
MMed,O
.3,NUMBER
Ban,PERSON
Hock,PERSON
Tan,PERSON
.,O
FRCP,O
.2.3,O
and,O
Terence,PERSON
Yi,PERSON
Shern,PERSON
Kee,PERSON
.,O
FRCP,O
.,O
FACP1,O
.2,O
e,O
present,DATE
a,O
case,O
of,O
asymptomatic,O
coronavirus,O
disease,CAUSE_OF_DEATH
2019,DATE
(,O
COVID,O
‐,O
19,NUMBER
),O
diagnosed,O
in,O
a,O
hemodialysis,O
patient,O
during,O
deceased,O
donor,O
renal,O
transplantation,O
(,O
DDRT,O
),O
evaluation,O
and,O
discuss,O
the,O
challenges,O
of,O
excluding,O
COVID,O
‐,O
19,NUMBER
before,O
transplantation,O
.,O
A,O
50,NUMBER
‐,O
year,DURATION
‐,O
old,O
woman,O
with,O
end,O
‐,O
stage,O
renal,O
disease,CAUSE_OF_DEATH
secondary,O
to,O
IgA,O
nephropathy,CAUSE_OF_DEATH
on,O
hemodialysis,O
was,O
called,O
up,O
as,O
first,ORDINAL
on,O
the,O
wait,O
‐,O
list,O
.,O
She,O
was,O
screened,O
for,O
with,O
the,O
addition,O
of,O
a,O
chest,O
computed,O
tomography,O
(,O
CT,STATE_OR_PROVINCE
),O
Our,O
patient,O
and,O
her,O
brother,O
.,O
her,O
only,O
household,O
contact,O
.,O
were,O
asymptomatic,O
.,O
had,O
no,O
known,O
contact,O
with,O
COVID,O
‐,O
19,NUMBER
cases,O
or,O
suspects,O
.,O
and,O
had,O
not,O
travelled,O
overseas,O
for,O
3,DURATION
months,DURATION
.,O
She,O
continued,O
her,O
work,O
as,O
a,O
hawker,O
but,O
wore,O
a,O
cloth,O
mask,O
for,O
all,O
activities,O
outside,O
her,O
home,O
.,O
except,O
during,O
exercise,O
.,O
On,O
admis,O
‐,O
sion,O
.,O
she,O
was,O
afebrile,O
.,O
with,O
a,O
respiratory,O
rate,O
of,O
18,NUMBER
breaths,O
/,O
min,DURATION
and,O
her,O
pulse,O
oximetry,O
reading,O
was,O
96,PERCENT
%,PERCENT
on,O
room,O
air,O
.,O
Physical,O
examination,O
revealed,O
bilateral,O
basal,O
lung,O
crepitations,O
without,O
signs,O
of,O
volume,O
overload,O
.,O
She,O
had,O
lymphopenia,O
though,O
her,O
white,O
cell,O
count,TITLE
was,O
normal,O
.,O
Her,O
chest,O
radiograph,O
revealed,O
bilateral,O
mild,O
.,O
ill,O
‐,O
defined,O
patchy,O
opacities,O
.,O
while,O
CT,STATE_OR_PROVINCE
of,O
the,O
chest,O
showed,O
bilateral,O
nodular,O
air,O
space,O
consolidation,O
.,O
predominantly,O
Depart,O
‐,O
ment,O
of,O
Renal,ORGANIZATION
Medicine,ORGANIZATION
.,O
Singapore,ORGANIZATION
General,ORGANIZATION
Hospital,ORGANIZATION
.,O
Singapore,COUNTRY
.,O
SingHealth,O
Duke,TITLE
‐,O
NUS,O
Transplant,O
Centre,O
.,O
Singapore,COUNTRY
.,O
Department,O
of,O
Infectious,O
Diseases,CAUSE_OF_DEATH
.,O
Singapore,ORGANIZATION
General,ORGANIZATION
Hospital,ORGANIZATION
.,O
Singapore,COUNTRY
.,O
De,O
‐,O
partment,O
of,O
Diagnostic,ORGANIZATION
Radiology,ORGANIZATION
.,O
Singapore,ORGANIZATION
General,ORGANIZATION
Hospital,ORGANIZATION
.,O
Singapore,COUNTRY
.,O
Correspondence,O
:,O
Quan,PERSON
Yao,PERSON
Ho,PERSON
.,O
MRCP,O
.,O
MMed,O
.,O
Department,O
of,O
Renal,O
Medicine,O
.,O
(,O
CCBY,O
‐,O
NC,STATE_OR_PROVINCE
‐,O
ND,STATE_OR_PROVINCE
),O
.,O
where,O
it,O
is,O
permissible,O
to,O
down,O
‐,O
load,O
and,O
share,O
the,O
work,O
provided,O
Transplantation,O
DIRECT,O
Nasopha,O
‐,O
ryngeal,O
swab,O
for,O
severe,O
acute,O
respiratory,O
syndrome,O
coronavirus,O
2,NUMBER
later,O
returned,O
positive,O
on,O
the,O
same,O
Transplantation,O
was,O
held,O
off,O
.,O
and,O
the,O
patient,O
was,O
immediately,O
transferred,O
to,O
an,O
isolation,O
ward,O
.,O
She,O
developed,O
a,O
temperature,O
of,O
37.6,NUMBER
C,O
the,DATE
following,DATE
morning,DATE
and,O
mild,O
symptoms,O
(,O
eg,O
.,O
cough,O
.,O
myalgia,O
.,O
vomiting,O
.,O
and,O
diarrhea,O
),O
only,O
from,O
day,DURATION
3,NUMBER
of,O
admission,O
(,O
D3,O
),O
.,O
She,O
did,O
not,O
require,O
supplemental,O
oxygen,O
.,O
and,O
her,O
symptoms,O
resolved,O
on,O
D10,O
.,O
Repeat,O
respiratory,O
swabs,O
first,ORDINAL
returned,O
negative,O
on,O
D20,O
.,O
The,O
optimal,O
strategy,O
to,O
exclude,O
COVID,O
‐,O
19,NUMBER
before,O
DDRT,O
is,O
unclear,O
.,O
With,O
significant,O
un,O
‐,O
linked,O
community,O
transmission,O
and,O
an,O
incubation,O
period,O
of,O
approx,O
‐,O
imately,O
2,DURATION
weeks,DURATION
.,O
COVID,O
‐,O
19,NUMBER
can,O
not,O
be,O
confidently,O
excluded,O
with,O
clinical,O
and,O
epidemiological,O
history,O
.,O
Dialysis,O
patients,O
may,O
have,O
minimal,O
symptoms,O
or,O
present,DATE
atypically,O
(,O
eg,O
.,O
with,O
predominantly,O
gastrointestinal,O
symptoms,O
),O
.2,NUMBER
Home,O
isolation,O
is,O
impossible,O
if,O
they,O
require,O
regular,O
hemodialysis,O
in,O
the,O
community,O
.,O
Laboratory,O
find,O
‐,O
ings,O
such,O
as,O
lymphopenia,O
are,O
nonspecific,O
.,O
Real,O
‐,O
time,O
reverse,O
transcriptase,O
polymerase,O
chain,O
reaction,O
for,O
severe,O
acute,O
respira,O
‐,O
tory,O
syndrome,O
coronavirus,O
2,NUMBER
on,O
respiratory,O
specimens,O
is,O
used,O
to,O
confirm,O
COVID,O
‐,O
19,NUMBER
.,O
but,O
its,O
sensitivity,O
may,O
be,O
affected,O
by,O
the,O
pa,O
‐,O
tients,O
functional,O
status,O
.,O
type,O
of,O
respiratory,O
specimen,O
.,O
and,O
col,O
‐,O
lection,O
technique3,O
and,O
has,O
been,O
reported,O
to,O
be,O
initially,O
nega,O
‐,O
tive,O
.,O
especially,O
in,O
mild,O
or,O
early,O
illness,CAUSE_OF_DEATH
.4,NUMBER
The,O
sensitivity,O
of,O
respiratory,O
swabs,O
within,O
a,O
short,O
time,O
frame,O
to,O
exclude,O
COVID,O
‐,O
19,NUMBER
may,O
be,O
limited,O
.,O
Chest,O
radiography,O
may,O
be,O
a,O
useful,O
adjunct,O
in,O
the,O
screening,O
of,O
COVID,O
‐,O
19,NUMBER
but,O
is,O
not,O
sensitive,O
in,O
mild,O
or,O
early,O
dis,O
‐,O
ease,O
.,O
In,O
a,O
recent,O
meta,O
‐,O
analysis,O
.,O
CT,STATE_OR_PROVINCE
was,O
suggested,O
to,O
be,O
more,O
sen,O
‐,O
sitive,O
than,O
real,O
‐,O
time,O
reverse,O
transcriptase,O
polymerase,O
chain,O
re,O
‐,O
action3,O
but,O
can,O
be,O
also,O
negative,O
in,O
mild,O
or,O
early,O
disease,CAUSE_OF_DEATH
.5,NUMBER
CT,STATE_OR_PROVINCE
findings,O
are,O
nonspecific,O
(,O
eg,O
.,O
pulmonary,O
congestion,O
may,O
mimic,O
vi,O
‐,O
ral,O
pneumonia,CAUSE_OF_DEATH
),O
which,O
can,O
add,O
further,O
complexity,O
to,O
patient,O
as,O
‐,O
sessment,O
.,O
Given,O
the,O
potentially,O
devastating,O
consequences,O
of,O
per,O
‐,O
itransplant,O
COVID,O
‐,O
19,NUMBER
.,O
we,O
find,O
it,O
necessary,O
to,O
exclude,O
COVID,O
‐,O
19,NUMBER
as,O
best,O
as,O
possible,O
before,O
DDRT,O
.,O
but,O
this,O
will,O
likely,O
remain,O
chal,O
‐,O
lenging,O
.,O
A,O
combination,O
of,O
clinical,O
.,O
molecular,O
.,O
and,O
radiological,O
investigations,O
may,O
help,O
detect,O
early,O
COVID,O
‐,O
19,NUMBER
but,O
may,O
not,O
elimi,O
‐,O
nate,O
Transplantation,O
DIRECT,O
the,O
risk,O
of,O
COVID,O
‐,O
19,NUMBER
especially,O
given,O
the,O
time,O
sensitivity,O
of,O
DDRT,O
.,O
The,O
risks,O
and,O
benefits,O
of,O
proceed,O
‐,O
ing,O
with,O
transplantation,O
during,O
this,O
pandemic,O
needs,O
to,O
be,O
care,O
‐,O
fully,O
considered,O
and,O
also,O
discussed,O
with,O
the,O
1,NUMBER
.,O
Chung,PERSON
SJ,PERSON
.,O
Tan,PERSON
EK,PERSON
.,O
Kee,PERSON
T,PERSON
.,O
et,O
al,O
.,O
Practical,O
considerations,O
for,O
solid,O
organ,O
transplan,O
‐,O
tation,O
during,O
the,O
COVID,O
‐,O
19,NUMBER
global,O
outbreak,O
:,O
the,O
experience,O
from,O
Singapore,COUNTRY
.,O
Transplant,O
Direct,O
.,O
2020,DATE
;,O
6,NUMBER
:,O
e554,NUMBER
.,O
2,NUMBER
.,O
Wang,PERSON
R,PERSON
.,O
Liao,PERSON
C,PERSON
.,O
He,O
H,O
.,O
et,O
al,O
.,O
COVID,O
‐,O
19,NUMBER
in,O
hemodialysis,O
patients,O
:,O
a,O
3,NUMBER
.,O
Kim,PERSON
H,PERSON
.,O
Hong,PERSON
H,PERSON
.,O
Yoon,PERSON
SH,PERSON
.,O
Diagnostic,O
performance,O
of,O
CT,STATE_OR_PROVINCE
and,O
reverse,O
transcriptase,O
‐,O
polymerase,O
chain,O
reaction,O
for,O
coronavirus,O
disease,CAUSE_OF_DEATH
4,NUMBER
.,O
Young,O
BE,O
.,O
Ong,O
SWX,O
.,O
Kalimuddin,PERSON
S,PERSON
.,O
et,O
al,O
.,O
Epidemiologic,O
features,O
and,O
clinical,O
course,O
of,O
patients,O
infected,O
with,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
in,O
Singapore,COUNTRY
.,O
5,NUMBER
.,O
Bernheim,PERSON
A,O
.,O
Mei,PERSON
X,PERSON
.,O
Huang,PERSON
M,O
.,O
et,O
al,O
.,O
Chest,O
CT,STATE_OR_PROVINCE
findings,O
in,O
coron,O
‐,O
avirus,O
disease,CAUSE_OF_DEATH
‐,O
19,NUMBER
(,O
COVID,O
‐,O
19,NUMBER
),O
:,O
relationship,O
to,O
duration,O
of,O
infec,O
‐,O
tion,O
.,O
